[Federal Register Volume 85, Number 26 (Friday, February 7, 2020)]
[Notices]
[Pages 7319-7320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02403]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Leveraging Big Data Science to Elucidate the

[[Page 7320]]

Mechanisms of HIV Activity and Interaction with Substance Use 
Disorder.
    Date: March 5, 2020.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Science Center, 
6001 Executive Boulevard, Room 4238, Rockville, MD 20852 (Telephone 
Conference Call).
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, 6001 Executive Boulevard, Room 4238, 
MSC 9550, Bethesda, MD 20892, 301-402-6020, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA Core and Research Center of Excellence Grant 
Program (P30/50 Clinical Trial Optional).
    Date: March 9-10, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard Marriott Bethesda Chevy Chase, 5520 Wisconsin 
Avenue, Chevy Chase, MD 20815.
    Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, National 
Institutes of Health, 6001 Executive Boulevard, Room 4234, Bethesda, 
MD 20892, 301-402-7371, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIH Pathway to Independence Award (K99/R00).
    Date: March 19, 2020.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Science Center, 
6001 Executive Boulevard, Room 4229, Rockville, MD 20852 (Telephone 
Conference Call).
    Contact Person: Susan O. McGuire, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 
4245, Rockville, MD 20852, 301-435-1426, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Alcohol and Other Substance Use Research Education 
Programs for Health Professionals (R25 Clinical Trial Not Allowed).
    Date: April 6, 2020.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Science Center, 
6001 Executive Boulevard, Room 4229, Rockville, MD 20852 (Telephone 
Conference Call).
    Contact Person: Susan O. McGuire, Ph.D., Scientific Review 
Officer Office, of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 
4245, Rockville, MD 20852, 301-435-1426, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: February 3, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-02403 Filed 2-6-20; 8:45 am]
BILLING CODE 4140-01-P